Evidence map›Paper›PMID 28743282›Full record

ArticleBMC research notes2017

A hospital based surveillance of metallo-beta-lactamase producing gram negative bacteria in Nepal by imipenem-EDTA disk method.

Pratigya Thapa, Dinesh Bhandari, Dhiraj Shrestha, Hiramani Parajuli, Prakash Chaudhary, Jyoti Amatya, Ritu Amatya

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Carbapenem Resistance inBioMed research international · 2024
    Article
  4. Article
  5. Public health action · 2021
    Article
  6. Article
  7. Article
  8. Prevalence of multidrug-resistance andIranian journal of microbiology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pratigya ThapaDepartment of Microbiology, Trichandra Multiple College, Ghantaghar, Kathmandu, Nepal. pratigyathapa1234@gmail.com.
Dinesh BhandariDepartment of Microbiology, Trichandra Multiple College, Ghantaghar, Kathmandu, Nepal.
Dhiraj ShresthaDepartment of Microbiology, Trichandra Multiple College, Ghantaghar, Kathmandu, Nepal.
Hiramani ParajuliDepartment of Microbiology, Trichandra Multiple College, Ghantaghar, Kathmandu, Nepal.
Prakash ChaudharyDepartment of Microbiology, Trichandra Multiple College, Ghantaghar, Kathmandu, Nepal.
Jyoti AmatyaDepartment of Microbiology, Trichandra Multiple College, Ghantaghar, Kathmandu, Nepal.
Ritu AmatyaDepartment of Microbiology, Nepal Medical College and Teaching Hospital, Kathmandu University, Dhulikhel, Nepal.
Nepal Medical College Teaching Hospital · NPTribhuvan University Teaching Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA rising threat of the rapid spread of acquired metallo-beta-lactamases (MBLs) among major Gram-negative pathogens is a matter of public health concern worldwide. Hence, for a low income nation like Nepal, surveillance data on MBL producing clinical isolates via a cost effective technique is necessary to prevent their dissemination as well as formulation and regulation of antimicrobial stewardship policy.

methodsThe prospective study was conducted at Nepal Medical College, Kathmandu from May to October, 2014 to assess the prevalence of MBL production among ceftazidime-resistant Gram-negative rods (GNRs) isolates. The samples were processed according to standard microbiological procedure following the Manual of clinical Microbiology. Isolated GNRs were subjected to susceptibility testing against the selected panel of antibiotics by Kirby- Bauer disc diffusion method and interpretation made in conformity with the Clinical and Laboratory Standards Institute (CLSI) guidelines. Ceftazidime-resistant isolates were subjected to the detection of MBL production by imipenem-EDTA combined disc (CD) method.

resultsAmong the Gram-negative isolates, 5.80% (21/362) were found to be MBL positive with Acinetobacter spp. showing the highest prevalence i.e. 85.71% (18/21), followed by P. aeruginosa i.e. 14.29% (3/21). None of the other cefazidime resistant gram negative bacteria tested were found to be positive for MBL production with all the positive isolates determined to be Multidrug resistant (MDR) strains.

conclusionThis study demonstrated a higher rate of resistance among P. aeruginosa and Acinetobacter spp. to a wide variety of antibiotic categories with an additional burden of MBL production within them, warranting a need for strict surveillance and rapid detection of MBL production among the GNRs.

Indexed as

HospitalsPopulation Surveillancebeta-LactamasesCeftazidimeDisk Diffusion Antimicrobial TestsEdetic AcidGram-Negative BacteriaHumansImipenemMicrobial Sensitivity TestsNepalbeta-LactamasesCeftazidimeEdetic AcidImipenemAntimicrobial resistanceCeftazidime-resistant Gram-negative rodsMetallo-beta-lactamaseSurveillance

Identifiers

PMID28743282
PMCPMC5526278
OpenAlexW2736362661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.